Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ASCENTRA-UC: PALI-2108 in Moderately to Severely Active Ulcerative Colitis
NCT07845487Phase 2Recruiting
- Sponsor
- Palisade Bio
- Start
- Aug 2026
- Primary completion
- Oct 2027
- Countries
- 12
01
Overview
A Phase 2 trial of PALI-2108 in ulcerative colitis (UC), sponsored by Palisade Bio. Started Aug 2026; status: recruiting.
02
Drugs
PALI-2108
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT07845487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07845487.